SPINK1
protein-codingserine peptidase inhibitor Kazal type 1, the group of Serine peptidase inhibitors, Kazal type
Gene summary
The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008185
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0008185
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008185
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Gastrointestinal; Oncologic
Intervention: Gastrointestinal; Endocrine; Oncologic
Rationale: Dietary measures (eg, low-fat diet with frequent feeding), hydration, and antioxidants, with avoidance of precipitants such as alcohol and tobacco, can beneficial in order to ameliorate episodes of pancreatitis; Individuals may be at increased risk of insulin-dependent, ketosis-resistant diabetes mellitus, and awareness may enable early diagnosis and management; Individuals may be at high risk of pancreatic cancer, and awareness may allow early diagnosis and treatment
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SPINK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001379610.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 56 | 2 | 58 | |||
| missense | 1 | 1 | 84 | 18 | 1 | 105 |
| nonsense | 2 | 1 | 1 | 4 | ||
| start loss | 2 | 1 | 1 | 4 | ||
| frameshift | 1 | 3 | 4 | |||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 7 | 12 | ||
| Total | 8 | 9 | 93 | 74 | 3 | 187 |
Highest pathogenic variant AF is 0.00011372789
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001366539.1 | 4 | MANE Select | |
| Ensembl | ENSP00000296695.5 | 4 | MANE Select | |
| RefSeq | NP_001341895.1 | 4 | Standard | |
| RefSeq | NP_003113.2 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Androgen Receptor Network in Prostate Cancer
Biological Process
- negative regulation of nitric oxide mediated signal transduction
- sperm capacitation
- negative regulation of peptidyl-tyrosine phosphorylation
- regulation of acrosome reaction
- negative regulation of calcium ion import
Molecular Function
- endopeptidase inhibitor activity
- serine-type endopeptidase inhibitor activity
- protein binding
Cellular Component
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296695
- Coding exons
- 4
- Length
- 7219
- Individuals with no LoFs
- 125456
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 82
- Defined
- 125538
- p
- 0.000327
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.123 | 45 | 42.7 | 1.05 | 0.00000216 | 501 |
| Missense (PolyPhen) | 13 | 14.521 | 0.89527 | 164 | ||
| Synonymous | -0.773 | 18 | 14.3 | 1.26 | 6.11e-7 | 146 |
| Loss of Function | 1.43 | 1 | 4.14 | 0.241 | 1.73e-7 | 54 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0033 | 0.0033 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00012 | 0.00012 | rare |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine protease inhibitor which exhibits anti-trypsin activity (PubMed:7142173). In the pancreas, protects against trypsin-catalyzed premature activation of zymogens (By similarity). {ECO:0000250|UniProtKB:P09036, ECO:0000269|PubMed:7142173}.;
- Disease
- DISEASE: Pancreatitis, hereditary (PCTT) [MIM:167800]: A disease characterized by pancreas inflammation, permanent destruction of the pancreatic parenchyma, maldigestion, and severe abdominal pain attacks. {ECO:0000269|PubMed:10691414, ECO:0000269|PubMed:10835640, ECO:0000269|PubMed:12974284, ECO:0000269|PubMed:18617776, ECO:0000269|PubMed:19888199}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Tropical calcific pancreatitis (TCP) [MIM:608189]: Idiopathic, juvenile, nonalcoholic form of chronic pancreatitis widely prevalent in several tropical countries. It can be associated with fibrocalculous pancreatic diabetes (FCPD) depending on both environmental and genetic factors. TCP differs from alcoholic pancreatitis by a much younger age of onset, pancreatic calcification, a high incidence of insulin dependent but ketosis resistant diabetes mellitus, and an exceptionally high incidence of pancreatic cancer. {ECO:0000269|PubMed:12011155, ECO:0000269|PubMed:12187509}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.179
Intolerance Scores
- LoFtool
- 0.542
- RVIS EVS
- 0.81
- RVIS percentile EVS
- 87.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.547
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |